276 related articles for article (PubMed ID: 31583686)
1. Unique and redundant roles of SOX2 and SOX17 in regulating the germ cell tumor fate.
Jostes SV; Fellermeyer M; Arévalo L; Merges GE; Kristiansen G; Nettersheim D; Schorle H
Int J Cancer; 2020 Mar; 146(6):1592-1605. PubMed ID: 31583686
[TBL] [Abstract][Full Text] [Related]
2. SOX2 is essential for in vivo reprogramming of seminoma-like TCam-2 cells to an embryonal carcinoma-like fate.
Nettersheim D; Heimsoeth A; Jostes S; Schneider S; Fellermeyer M; Hofmann A; Schorle H
Oncotarget; 2016 Jul; 7(30):47095-47110. PubMed ID: 27283990
[TBL] [Abstract][Full Text] [Related]
3. Mechanism and Role of SOX2 Repression in Seminoma: Relevance to Human Germline Specification.
Kushwaha R; Jagadish N; Kustagi M; Mendiratta G; Seandel M; Soni R; Korkola JE; Thodima V; Califano A; Bosl GJ; Chaganti RSK
Stem Cell Reports; 2016 May; 6(5):772-783. PubMed ID: 27132888
[TBL] [Abstract][Full Text] [Related]
4. The seminoma cell line TCam-2 is sensitive to HDAC inhibitor depsipeptide but tolerates various other chemotherapeutic drugs and loss of NANOG expression.
Nettersheim D; Gillis A; Biermann K; Looijenga LH; Schorle H
Genes Chromosomes Cancer; 2011 Dec; 50(12):1033-42. PubMed ID: 21987446
[TBL] [Abstract][Full Text] [Related]
5. Differential expression of SOX2 and SOX17 in testicular germ cell tumors.
Nonaka D
Am J Clin Pathol; 2009 May; 131(5):731-6. PubMed ID: 19369635
[TBL] [Abstract][Full Text] [Related]
6. The cancer/testis-antigen PRAME supports the pluripotency network and represses somatic and germ cell differentiation programs in seminomas.
Nettersheim D; Arndt I; Sharma R; Riesenberg S; Jostes S; Schneider S; Hölzel M; Kristiansen G; Schorle H
Br J Cancer; 2016 Aug; 115(4):454-64. PubMed ID: 27441500
[TBL] [Abstract][Full Text] [Related]
7. Differential expression of SOX17 and SOX2 in germ cells and stem cells has biological and clinical implications.
de Jong J; Stoop H; Gillis AJ; van Gurp RJ; van de Geijn GJ; Boer Md; Hersmus R; Saunders PT; Anderson RA; Oosterhuis JW; Looijenga LH
J Pathol; 2008 May; 215(1):21-30. PubMed ID: 18348160
[TBL] [Abstract][Full Text] [Related]
8. Oct4 switches partnering from Sox2 to Sox17 to reinterpret the enhancer code and specify endoderm.
Aksoy I; Jauch R; Chen J; Dyla M; Divakar U; Bogu GK; Teo R; Leng Ng CK; Herath W; Lili S; Hutchins AP; Robson P; Kolatkar PR; Stanton LW
EMBO J; 2013 Apr; 32(7):938-53. PubMed ID: 23474895
[TBL] [Abstract][Full Text] [Related]
9. Expression and interdependencies of pluripotency factors LIN28, OCT3/4, NANOG and SOX2 in human testicular germ cells and tumours of the testis.
Gillis AJ; Stoop H; Biermann K; van Gurp RJ; Swartzman E; Cribbes S; Ferlinz A; Shannon M; Oosterhuis JW; Looijenga LH
Int J Androl; 2011 Aug; 34(4 Pt 2):e160-74. PubMed ID: 21631526
[TBL] [Abstract][Full Text] [Related]
10. BMP Inhibition in Seminomas Initiates Acquisition of Pluripotency via NODAL Signaling Resulting in Reprogramming to an Embryonal Carcinoma.
Nettersheim D; Jostes S; Sharma R; Schneider S; Hofmann A; Ferreira HJ; Hoffmann P; Kristiansen G; Esteller MB; Schorle H
PLoS Genet; 2015 Jul; 11(7):e1005415. PubMed ID: 26226633
[TBL] [Abstract][Full Text] [Related]
11. Establishment of a versatile seminoma model indicates cellular plasticity of germ cell tumor cells.
Nettersheim D; Westernströer B; Haas N; Leinhaas A; Brüstle O; Schlatt S; Schorle H
Genes Chromosomes Cancer; 2012 Jul; 51(7):717-26. PubMed ID: 22489004
[TBL] [Abstract][Full Text] [Related]
12. Differential expression of preferentially expressed antigen in melanoma (PRAME) in testicular germ cell tumors - A comparative study with SOX17.
Zhou Y; Rothrock A; Murugan P; Li F; Bu L
Exp Mol Pathol; 2022 Jun; 126():104761. PubMed ID: 35390309
[TBL] [Abstract][Full Text] [Related]
13. SOX2 and PRAME in the "reprogramming" of seminoma cells.
Orsatti A; Sirolli M; Ambrosi F; Franceschini T; Giunchi F; Franchini E; Grillini M; Massari F; Mollica V; Bianchi FM; Colecchia M; Fiorentino M; Ricci C
Pathol Res Pract; 2022 Sep; 237():154044. PubMed ID: 35930824
[TBL] [Abstract][Full Text] [Related]
14. Differentiation of human embryonal carcinomas in vitro and in vivo reveals expression profiles relevant to normal development.
Skotheim RI; Lind GE; Monni O; Nesland JM; Abeler VM; Fosså SD; Duale N; Brunborg G; Kallioniemi O; Andrews PW; Lothe RA
Cancer Res; 2005 Jul; 65(13):5588-98. PubMed ID: 15994931
[TBL] [Abstract][Full Text] [Related]
15. Establishment and characterization of a new human extragonadal germ cell line, SEM-1, and its comparison with TCam-2 and JKT-1.
Russell SM; Lechner MG; Mokashi A; Megiel C; Jang JK; Taylor CR; Looijenga LH; French CA; Epstein AL
Urology; 2013 Feb; 81(2):464.e1-9. PubMed ID: 23374840
[TBL] [Abstract][Full Text] [Related]
16. Conversion of Sox17 into a pluripotency reprogramming factor by reengineering its association with Oct4 on DNA.
Jauch R; Aksoy I; Hutchins AP; Ng CK; Tian XF; Chen J; Palasingam P; Robson P; Stanton LW; Kolatkar PR
Stem Cells; 2011 Jun; 29(6):940-51. PubMed ID: 21472822
[TBL] [Abstract][Full Text] [Related]
17. The plasticity of germ cell cancers and its dependence on the cellular microenvironment.
Nettersheim D; Schorle H
J Cell Mol Med; 2017 Aug; 21(8):1463-1467. PubMed ID: 28244655
[TBL] [Abstract][Full Text] [Related]
18. Genome-wide expression profiling reveals new insights into pathogenesis and progression of testicular germ cell tumors.
Biermann K; Heukamp LC; Steger K; Zhou H; Franke FE; Sonnack V; Brehm R; Berg J; Bastian PJ; Muller SC; Wang-Eckert L; Buettner R
Cancer Genomics Proteomics; 2007; 4(5):359-67. PubMed ID: 17993720
[TBL] [Abstract][Full Text] [Related]
19. High-throughput microRNAome analysis in human germ cell tumours.
Gillis AJ; Stoop HJ; Hersmus R; Oosterhuis JW; Sun Y; Chen C; Guenther S; Sherlock J; Veltman I; Baeten J; van der Spek PJ; de Alarcon P; Looijenga LH
J Pathol; 2007 Nov; 213(3):319-28. PubMed ID: 17893849
[TBL] [Abstract][Full Text] [Related]
20. Expression of the RNA component of human telomerase in adult testicular germ cell neoplasia.
Delgado R; Rathi A; Albores-Saavedra J; Gazdar AF
Cancer; 1999 Nov; 86(9):1802-11. PubMed ID: 10547554
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
